John P. A. Ioannidis
Stanford University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
COVID-19 and healthcare impacts
Strong evidence · 2 supporting papers · latest 2026
Academic integrity and plagiarism
Strong evidence · 3 supporting papers · latest 2026
Meta-analysis and systematic reviews
Strong evidence · 7 supporting papers · latest 2026
Genetic Associations and Epidemiology
Strong evidence · 1 supporting paper · latest 2026
Liver Disease Diagnosis and Treatment
Strong evidence · 1 supporting paper · latest 2026
Chronic Kidney Disease and Diabetes
Strong evidence · 1 supporting paper · latest 2026
Biomedical Text Mining and Ontologies
Solid evidence · 1 supporting paper · latest 2026
Statistical Methods in Clinical Trials
Solid evidence · 3 supporting papers · latest 2026
Publications (15)
A genetic and clinical risk factor algorithm to aid in identifying new cases of chronic kidney disease from the general population
2026DOIPMID 42488352
Cost of Retracted Articles to the NIH: a Living Analysis
2026DOIPMID 42465960
Zombie trials are often monocentric and cluster within fabricated evidence “factories”: a cohort study of 236 retracted randomized controlled trials with confirmed data fabrication
2026DOI
Why the unrestricted weighted least squares should be routinely reported in medical meta-analyses
2026DOI
Long-term mortality rate changes and inverse patterns for pandemic and post-pandemic excess mortality
2026DOI
Post-pandemic mortality patterns and COVID-19 burden considering multiple death causes
2026DOIPMID 42776466
Use of Statistics to Assess Serious Adverse Events in Clinical Trials of New Drugs: Cross-Sectional Study of FDA Review Memos
2026DOIPMID 42527841
TrialScout links published results to trial registrations using a large language model
2026DOIPMID 42648652
CONSORT 2025 statement: updated guideline for reporting randomised trials
2026DOI
Uptake and Implementation of Multiverse-style Analyses Across 613 Studies
2026DOI
retracted zombie trials dataset
2026DOI
Target trial emulation lacks the Magic of Randomization: HARKing and terminology can mislead
2026DOIPMID 42557050
Agentic Laboratories of the Future: Towards World Models for Scientific Discovery
2026DOI
Life Expectancy: Ultra Rich
2026
Negligible participation in the scientific literature of AI unicorn startups
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Stanford University
Source: OpenAlex · retrieved 2026-09-27
Source: ScienceWe Extractor · retrieved 2026-09-27